Ems-Chemie Holding AG/€EMSN
1D1W1MYTD1Y5YMAX
Capital at risk
About Ems-Chemie Holding AG
Ems-Chemie Holding AG operates in the specialty chemicals industry, focusing on the development and manufacturing of high-performance polymers and specialty chemicals. The company’s core products include polyamide and polyester products used in automobiles, electronics, and industrial applications, alongside numerous specialty chemicals for manufacturing and consumer goods sectors. Founded in 1936, Ems-Chemie is headquartered in Domat/Ems, Switzerland. Its strategic positioning is bolstered by a focus on innovation and tailoring solutions to specific customer needs across various sectors. The company maintains a significant international presence, supplying products to global markets.
- Ticker
- €EMSN
- Sector
- Materials
- Primary listing
- XGAT
- Employees
- 2,617
- Headquarters
- Domat/Ems, Switzerland
- Website
- www.ems-group.com
EMSN Metrics
BasicAdvanced
€20B
39.65
€21.45
0.81
€19.59
1.83%
Price and volume
Market cap
€20B
Beta
0.81
52-week high
€887.00
52-week low
€569.50
Average daily volume
13K
Dividend rate
€19.59
Financial strength
Current ratio
5.184
Quick ratio
3.117
Long term debt to equity
0.002
Total debt to equity
0.015
Dividend payout ratio (TTM)
85.06%
Interest coverage (TTM)
644.57%
Profitability
EBITDA (TTM)
665.508
Gross margin (TTM)
48.82%
Net profit margin (TTM)
24.45%
Operating margin (TTM)
29.93%
Effective tax rate (TTM)
18.37%
Revenue per employee (TTM)
€782,950
Management effectiveness
Return on assets (TTM)
14.34%
Return on equity (TTM)
22.71%
Valuation
Price to earnings (TTM)
39.645
Price to revenue (TTM)
9.693
Price to book
8.96
Price to tangible book (TTM)
9.21
Price to free cash flow (TTM)
34.094
Free cash flow yield (TTM)
2.93%
Free cash flow per share (TTM)
24.946
Dividend yield (TTM)
2.30%
Forward dividend yield
1.83%
Growth
Revenue change (TTM)
-3.17%
Earnings per share change (TTM)
2.66%
3-year revenue growth (CAGR)
-6.07%
10-year revenue growth (CAGR)
0.02%
3-year earnings per share growth (CAGR)
-1.25%
10-year earnings per share growth (CAGR)
1.53%
3-year dividend per share growth (CAGR)
-2.38%
10-year dividend per share growth (CAGR)
2.91%
Bulls say / Bears say
In H1 2026, EMS-Chemie’s operating income rose 4.7% to CHF 310 million, with the EBIT margin widening to 30.6% from 29.1%, prompting a slight upgrade to its 2026 net sales forecast (Reuters).
Growth in the first half was underpinned by innovative, high-margin new business across all regions, demonstrating the effectiveness of EMS-Chemie’s R&D and its ability to capture specialty chemical market niches (Reuters).
The board plans to propose a total dividend of CHF 18.40 per share for 2026—up from CHF 17.25 the prior year—reflecting strong free cash flow generation and a commitment to shareholder returns (Reuters).
EMS-Chemie’s Q1 2026 net sales fell 6.7% to CHF 487 million as the significantly stronger Swiss franc erased gains from higher volumes, underscoring material FX risks to revenue growth (Reuters).
Despite a slight upward revision, EMS still forecasts full-year 2026 net sales to remain marginally below 2025 levels due to persistent currency headwinds, indicating constrained top-line growth potential (Reuters).
The company cited inconsistent U.S. trade policy and escalating Middle East conflict as headwinds to consumer and business sentiment, highlighting geopolitical uncertainties that could disrupt supply chains and demand (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 21 Aug 2026.
Upcoming events
No upcoming events
Funds containing EMSN
AllEURGBPUSD
Fund name | Fund size | €EMSN weighting |
|---|---|---|
SPDR MSCI World Materials€WMAT | €198M | 0.22% |
L&G Global Quality Dividends£LDGG | £279M | 0.17% |
Vanguard FTSE Developed Europe ex UK€VERX | €3.4B | 0.06% |
Vanguard FTSE Developed Europe ex UK£VERX | £2.9B | 0.06% |
Xtrackers MSCI Europe£XMEU | £6.7B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.